University of Leicester
Browse
journal.pmed.0020064.pdf (103.37 kB)

Antifibrinolytic agents in traumatic haemorrhage.

Download (103.37 kB)
journal contribution
posted on 2012-10-24, 09:02 authored by Timothy J. Coats, Beverly Hunt, Ian Roberts, Haleema Shakur
This article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage), a large, multi-centre, randomised controlled trial of a simple and widely practicable treatment for traumatic hemorrhage. The rationale for the trial and contact details for those who would like to take part are given below. [Introduction]

History

Citation

PLOS Medicine, 2005, 2 (3), e64

Version

  • VoR (Version of Record)

Published in

PLOS Medicine

Publisher

Public Library of Science

eissn

1549-1676

Copyright date

2005

Available date

2012-10-24

Publisher DOI

Publisher version

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020064

Language

eng

Administrator link

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Keywords

    Antifibrinolytic AgentsHemorrhageHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicWounds and Injuries

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC